TITLE

Optimal PT-INR after Prosthetic Valve Replacement: Queen Sirikit Heart Center's Experience

PUB. DATE
April 2010
SOURCE
Thai Journal of Surgery;Apr-Jun2010, Vol. 31 Issue 2, p54
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
61251992

 

Related Articles

  • Cortical Blindness and Bilateral Occipital Haemorrhage due to Warfarin Overdose. Özgür Erdoðan, Mehmet; Yorulmaz, Rasim; Tayfur, Ýsmail; Giritli, Özlem; Telli Erdoðan, Seçil // Journal of Academic Emergency Medicine Case Reports / Akademik A;2013, Vol. 4 Issue 2, p73 

    Bleeding is a common complication of anticoagulant agents. Rising numbers of patients requiring warfarin, as well as increasing long term use, causes some haemorraghic complications. Intracerebral haemorrhage is one of these complications. An 88 year old patient was admitted to our emergency...

  • Warfarin overdose.  // Reactions Weekly;5/19/2007, Issue 1152, p27 

    The article describes the case of an older man who developed endotension after receiving an inadvertent overdose of warfarin. Endotension characterizes by increasing aneurysm sac diameter in the absence of an endoleak. The patient experienced dyspnea, subconjunctival hemorrhages and fatigue...

  • Prophylactic Anticoagulant Therapy in the Orthopedic Patient. Neu Jr., Leo T.; Waterfield, Jim R.; Ash, Charles J. // Annals of Internal Medicine;Mar65, Vol. 62 Issue 3, p463 

    Focuses on a study of orthopedic patients who suffered trauma of the pelvis and lower extremities, to determine the value of routine prophylactic warfarin sodium anticoagulation in the prevention of thromboembolic phenomena. Significance of the variation between anticoagulated patients from the...

  • Cortical Blindness and Bilateral Occipital Haemorrhage due to Warfarin Overdose. Erdoğan, Mehmet Özgür; Yorulmaz, Rasim; Tayfur, İsmail; Giritli, Özlem; Erdoğan, Seçil Telli // Journal of Academic Emergency Medicine Case Reports / Akademik A;2013, Vol. 4 Issue 2, p73 

    Bleeding is a common complication of anticoagulant agents. Rising numbers of patients requiring warfarin, as well as increasing long term use, causes some haemorraghic complications. Intracerebral haemorrhage is one of these complications. An 88 year old patient was admitted to our emergency...

  • Managing Outpatient Anticoagulation. Jackson, Carol Mackenzie // Clinician Reviews;Feb2008, Vol. 18 Issue 2, p28 

    The article offers a practical guide to managing outpatient anticoagulation therapy (OACT), primarily for patients taking warfarin. Such therapy may be aimed toward primary or secondary prevention of thromboembolism. The three-part therapeutic process involves categorizing the patient...

  • Bleeding, Vertebral Fractures and Vascular Calcifications in Patients Treated with Warfarin: Hope for Lower Risks with Alternative Therapies. Fusaro, Maria; Crepaldi, Gaetano; Maggi, Stefania; D'Angelo, Angela; Calò, Lorenzo; Miozzo, Davide; Fornasieri, Alessandro; Gallieni, Maurizio // Current Vascular Pharmacology;Nov2011, Vol. 9 Issue 6, p763 

    Anticoagulant therapy in patients with atrial fibrillation requires careful evaluation because its benefits i.e. prevention of thromboembolism, must be greater than the risk of bleeding. Patients at higher risk of thrombosis are evaluated through specific scores, such as the CHA2DS2VASc, coupled...

  • Edoxaban was noninferior to warfarin for preventing recurrent venous thromboembolism, with less bleeding. Thomé, Stephan // Annals of Internal Medicine;1/21/2014, Vol. 160 Issue 2, Special Section pJC4 

    The article discusses a study which compares edoxaban with warfarin for preventing recurrent venous thromboembolism (VTE). The study was conducted on adults with objectively diagnosed acute symptomatic deep venous thrombosis (DVT) and found that edoxaban was noninferior to warfarin for...

  • lesson of the month (2). Carroll, Amy; Griffiths, Linda; Mahadevan, Vaikom; Dua, Jaspal; Thachil, Jecko // Clinical Medicine;Apr2013, Vol. 13 Issue 2, p211 

    The article presents a case study of a 36-year-old Caucasian male presented who had been anti-coagulated since a young age for surgically treated cyanotic congenital heart disease. The article also discusses increased risk of thrombosis due to Fontan operation and anti-coagulation. The warfare...

  • Rivaroxaban for VTE prevention. Elliott, William T. // Clinical Cardiology Alert;Apr2013 Pharmacology Watch, p2 

    The article reports that according to a study, Rivaroxaban, an oral Xa inhibitor, is as effective as enoxaparin in preventing venous thromboembolism (VTE) in patients with acute medical illnesses, but has a higher risk of bleeding.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics